Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors

NCT02684318 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

100

Enrollment

INDIV

Sponsor class

Conditions

Advanced Cancer
Ovarian Cancer
Endometrial Cancer
Breast Cancer

Interventions

DRUG: PM01183 + olaparib

Sponsor

Poveda, Andrés, M.D.

Collaborators

[object Object]
[object Object]